TECENTRIQ

Concentrate for solution for infusion, 1200mg
RxActive license

Active substance (INN)

atezolizumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength1200mg
PackagingUkupno 1 bočica staklena sa 20ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FF05)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateJanuary 27, 2026

Analogs in Montenegro

1

Other medicines with the same active substance

TecentriqRx
Solution for injection, 1875mgF. Hoffmann-La Roche AG
Source: CInMED register